NASDAQ:IBB - iShares Nasdaq Biotechnology ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding iShares Nasdaq Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $116.88 -2.62 (-2.19 %) (As of 01/26/2020 04:00 PM ET) Add Compare Today's Range$116.27Now: $116.88▼$120.0050-Day Range$116.88MA: $120.72▼$123.5052-Week Range$96.03Now: $116.88▼$123.74Volume4.31 million shsAverage Volume2.70 million shsMarket Capitalization$7.23 billionP/E RatioN/ADividend Yield0.17%Beta1.38 ProfileAdvanced ChartDividendFinancialsInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. Read More… Basic Details Issuer BlackRock Fund NameiShares Nasdaq Biotechnology ETF Tax ClassificationRegulated Investment Company SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/A Fund Focus Asset ClassEquity BenchmarkNASDAQ Biotechnology Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$7.70 billion Average Daily Volume$2.62 million Discount/Premium0.08% ETF Expenses Management Fee0.47% Other Expenses0.00% Total Expenses0.47% Fee Waiver0.00% Net Expenses0.47%Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorBlackRock Fund Advisors CustodianState Street Bank and Trust Company DistributorBlackRock Investments, LLC Transfer AgentState Street Bank and Trust Company Trustee Lead Market MakerVirtu Financial Receive IBB News and Ratings via Email Sign-up to receive the latest news and ratings for IBB and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:IBB Rates by TradingView iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Frequently Asked Questions What is iShares Nasdaq Biotechnology ETF's stock symbol? iShares Nasdaq Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB." How often does iShares Nasdaq Biotechnology ETF pay dividends? What is the dividend yield for iShares Nasdaq Biotechnology ETF? iShares Nasdaq Biotechnology ETF declared a quarterly dividend on Monday, December 16th. Stockholders of record on Tuesday, December 17th will be given a dividend of $0.0578 per share on Friday, December 20th. This represents a $0.23 annualized dividend and a dividend yield of 0.20%. The ex-dividend date is Monday, December 16th. View iShares Nasdaq Biotechnology ETF's Dividend History. When did iShares Nasdaq Biotechnology ETF's stock split? How did iShares Nasdaq Biotechnology ETF's stock split work? iShares Nasdaq Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Nasdaq Biotechnology ETF stock prior to the split would have 300 shares after the split. Has iShares Nasdaq Biotechnology ETF been receiving favorable news coverage? Media headlines about IBB stock have trended extremely negative on Sunday, according to InfoTrie Sentiment. The research firm ranks the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. iShares Nasdaq Biotechnology ETF earned a coverage optimism score of -4.5 on InfoTrie's scale. They also assigned news coverage about the financial services provider a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near term. View News Stories for iShares Nasdaq Biotechnology ETF. Who are some of iShares Nasdaq Biotechnology ETF's key competitors? Some companies that are related to iShares Nasdaq Biotechnology ETF include DNP Select Income Fund (DNP), Nuveen Municipal Value Fund (NUV), Adams Diversified Equity Fund (ADX), PIMCO Corporate&Income Opportunity Fund (PTY), Tri-Continental (TY), Gabelli Equity Trust (GAB), Hercules Capital (HTGC), Royce Value Trust (RVT), Liberty All-Star Equity Fund (USA), Boulder Growth & Income Fund (BIF), Apollo Investment (AINV), AllianceBernstein Global Hgh Incm Fd (AWF), PIMCO High Income Fund (PHK), General American Investors (GAM) and Tortoise Energy Infrastructure (TYG). What other stocks do shareholders of iShares Nasdaq Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Nasdaq Biotechnology ETF investors own include NVIDIA (NVDA), Alibaba Group (BABA), Netflix (NFLX), Bank of America (BAC), Walt Disney (DIS), Tesla (TSLA), Gilead Sciences (GILD), Cisco Systems (CSCO), First Solar (FSLR) and Micron Technology (MU). Who are iShares Nasdaq Biotechnology ETF's key executives? iShares Nasdaq Biotechnology ETF's management team includes the folowing people: George G. C. Parker Ph.D., Independent Chairman of the Board of TrusteesMichael Arthur Latham, President, TrusteeJack Gee, Chief Financial Officer, TreasurerGeoffrey D. Flynn, Chief Operating Officer, Executive Vice President, Bio & Compensation - Amy Schioldager, Executive Vice PresidentIra P. Shapiro, Vice President, Chief Legal OfficerMatt Tucker, Vice President, Bio & Compensation - Eilleen M. Clavere, SecretaryCecilia H. Herbert, Independent TrusteeCharles A. Hurty, Independent Trustee Who are iShares Nasdaq Biotechnology ETF's major shareholders? iShares Nasdaq Biotechnology ETF's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Janney Capital Management LLC (0.31%), Valicenti Advisory Services Inc. (0.13%), Janney Montgomery Scott LLC (0.12%), Neville Rodie & Shaw Inc. (0.10%), Calamos Advisors LLC (0.10%) and Appleton Partners Inc. MA (0.08%). Which major investors are selling iShares Nasdaq Biotechnology ETF stock? IBB stock was sold by a variety of institutional investors in the last quarter, including Commerzbank Aktiengesellschaft FI, Diligent Investors LLC, Kistler Tiffany Companies LLC, Winfield Associates Inc., New Potomac Partners LLC, Neville Rodie & Shaw Inc., Quattro Financial Advisors LLC and Neumann Capital Management LLC. Which major investors are buying iShares Nasdaq Biotechnology ETF stock? IBB stock was acquired by a variety of institutional investors in the last quarter, including Janney Capital Management LLC, CHURCHILL MANAGEMENT Corp, Mirador Capital Partners LP, Calamos Advisors LLC, Bay Rivers Group, Tocqueville Asset Management L.P., Alpha Cubed Investments LLC and Hamilton Wealth LLC. How do I buy shares of iShares Nasdaq Biotechnology ETF? Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is iShares Nasdaq Biotechnology ETF's stock price today? One share of IBB stock can currently be purchased for approximately $116.88. How big of a company is iShares Nasdaq Biotechnology ETF? iShares Nasdaq Biotechnology ETF has a market capitalization of $7.23 billion. View Additional Information About iShares Nasdaq Biotechnology ETF. MarketBeat Community Rating for iShares Nasdaq Biotechnology ETF (NASDAQ IBB)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 148 (Vote Outperform)Underperform Votes: 144 (Vote Underperform)Total Votes: 292MarketBeat's community ratings are surveys of what our community members think about iShares Nasdaq Biotechnology ETF and other stocks. Vote "Outperform" if you believe IBB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IBB will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/26/2020 by MarketBeat.com StaffFeatured Article: How accurate is the Rule of 72?
